Evidence map›Paper›PMID 35719891›Full record

ArticlePNAS nexus2022

HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration.

Muthukumar Balasubramaniam, Benem-Orom Davids, Alex Bryer, Chaoyi Xu, Santosh Thapa, Jiong Shi, Christopher Aiken, Jui Pandhare, Juan R Perilla, Chandravanu Dash

Open access · goldAbstract read
In one paragraph

Article in PNAS nexus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Muthukumar BalasubramaniamThe Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN - 37208, USA.
Benem-Orom DavidsThe Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN - 37208, USA.
Alex BryerDepartment of Chemistry, University of Delaware, Newark, DE - 19716, USA.
Chaoyi XuDepartment of Chemistry, University of Delaware, Newark, DE - 19716, USA.
Santosh ThapaThe Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN - 37208, USA.
Jiong ShiDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN - 37232, USA.
Christopher AikenDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN - 37232, USA.
Jui PandhareThe Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN - 37208, USA.
Juan R PerillaDepartment of Chemistry, University of Delaware, Newark, DE - 19716, USA.ORCID https://orcid.org/0000-0003-1171-6816
Chandravanu DashThe Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN - 37208, USA.ORCID https://orcid.org/0000-0003-4466-8355
Meharry Medical College · USUniversity of Delaware · USVanderbilt University Medical Center · US

Funding

The RCMI Program in Health Disparities Research at Meharry Medical College - SupplementU54MD007586 · NIMHD · MEHARRY MEDICAL COLLEGE · PI Samuel Evans Adunyah · 2017 to 2026
$48.2M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Koethe · 2015 to 2026
$27.5M
Role of GRIN2 in ART and SUD associated neurological deficits.R01DA057204 · NIDA · MEHARRY MEDICAL COLLEGE · PI Chandravanu Dash · 2022 to 2026
$3.7M
Spatiotemporal Staging of the HIV-1 Preintegration complexR01AI170228 · NIAID · MEHARRY MEDICAL COLLEGE · PI Chandravanu Dash · 2022 to 2026
$2.8M
Role of the Viral Capsid in HIV-1 IntegrationR01AI136740 · NIAID · MEHARRY MEDICAL COLLEGE · PI Chandravanu Dash · 2019 to 2026
$2.2M
Enhancing Virology Training of Underrepresented Minority Students through Summer ResearchR25AI164610 · NIAID · MEHARRY MEDICAL COLLEGE · PI DASH, CHANDRAVANU · 2021 to 2025
$1.8M
Role of the Viral Capsid in HIV-1 Integration.R56AI122960 · NIAID · MEHARRY MEDICAL COLLEGE · PI DASH, CHANDRAVANU · 2016 to 2016
$376k
NIAID NIH HHS P30 AI110527NIAID NIH HHS R01 AI136740NIAID NIH HHS R01 AI170228NIAID NIH HHS R25 AI164610NIAID NIH HHS R56 AI122960NIDA NIH HHS R01 DA057204NIMHD NIH HHS U54 MD007586
6 · The paper itself

Abstract

HIV-1 replication is durably controlled without antiretroviral therapy (ART) in certain infected individuals called elite controllers (ECs). These individuals express specific human leukocyte antigens (HLA) that tag HIV-infected cells for elimination by presenting viral epitopes to CD8+ cytotoxic T-lymphocytes (CTL). In HIV-infected individuals expressing HLA-B27, CTLs primarily target the viral capsid protein (CA)-derived KK10 epitope. While selection of CA mutation R264K helps HIV-1 escape this potent CTL response, the accompanying fitness cost severely diminishes virus infectivity. Interestingly, selection of a compensatory CA mutation S173A restores HIV-1 replication. However, the molecular mechanism(s) underlying HIV-1 escape from this ART-free virus control by CTLs is not fully understood. Here, we report that the R264K mutation-associated infectivity defect arises primarily from impaired HIV-1 DNA integration, which is restored by the S173A mutation. Unexpectedly, the integration defect of the R264K variant was also restored upon depletion of the host cyclophilin A. These findings reveal a nuclear crosstalk between CA and HIV-1 integration as well as identify a previously unknown role of cyclophilin A in viral DNA integration. Finally, our study identifies a novel immune escape mechanism of an HIV-1 variant escaping a CA-directed CTL response.

Indexed as

capsidcytotoxic T lymphocytes (CTL)human immunodeficiency virus (HIV)integrationreverse transcription

Identifiers

PMID35719891
PMCPMC9198661
OpenAlexW4283220727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.